AMRN Logo

Amarin Corporation plc (AMRN) 

NASDAQ$0.4138
Market Cap
$170.18M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
291 of 924
Rank in Industry
167 of 527

AMRN Insider Trading Activity

AMRN Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$102,4001100
Sells
$000

Related Transactions

Berg AaronPresident and CEO1$102,4000$0$102,400

About Amarin Corporation plc

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with â€¦

Insider Activity of Amarin Corporation plc

Over the last 12 months, insiders at Amarin Corporation plc have bought $102,400 and sold $0 worth of Amarin Corporation plc stock.

On average, over the past 5 years, insiders at Amarin Corporation plc have bought $174,734 and sold $5.19M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Berg Aaron (President and CEO) — $102,400.

The last purchase of 160,000 shares for transaction amount of $102,400 was made by Berg Aaron (President and CEO) on 2024‑08‑02.

List of Insider Buy and Sell Transactions, Amarin Corporation plc

2024-08-02PurchaseBerg AaronPresident and CEO
160,000
0.0389%
$0.64$102,400-10.08%
2024-01-22PurchaseHolt PatrickPresident and CEO
14,426
0.0033%
$1.09$15,724-39.29%
2023-12-12SaleKetchum Steven BChief Scientific Officer
34,131
0.0084%
$0.79$26,963-0.54%
2023-08-16PurchaseHolt PatrickPresident and CEO
300,000
0.0723%
$1.04$312,315-18.77%
2022-06-13PurchaseWOLD OLSEN PER
55,000
0.0137%
$1.69$92,730-21.76%
2021-12-15PurchaseZakrzewski Joseph Sdirector
2,000
0.0005%
$3.15$6,310-52.31%
2021-12-14PurchaseZakrzewski Joseph Sdirector
10,000
0.0025%
$3.27$32,689-52.00%
2021-08-12SaleKalb Michael WayneSVP and CFO
120,000
0.0282%
$5.25$630,240-41.05%
2021-06-04PurchaseSTACK DAVID Mdirector
10,000
0.0026%
$4.54$45,350-17.42%
2021-06-03PurchaseSTACK DAVID Mdirector
5,000
0.0013%
$4.62$23,115-19.61%
2021-02-01SaleKetchum Steven BChief Scientific Officer
435,456
0.11%
$8.06$3.51M-39.85%
2021-01-27SaleKetchum Steven BChief Scientific Officer
843,258
0.2332%
$8.01$6.76M-33.52%
2020-11-30PurchaseSTACK DAVID Mdirector
50,000
0.0125%
$4.86$243,035+1.61%
2020-11-11SaleTHERO JOHN FPresident and CEO
827,130
0.2094%
$4.07$3.36M+22.63%
2020-11-10SaleTHERO JOHN FPresident and CEO
307,680
0.0792%
$4.13$1.27M+22.63%
2020-03-04SaleTHERO JOHN FPresident and CEO
400,000
0.1106%
$15.99$6.4M-58.77%
2020-01-03SaleZakrzewski Joseph Sdirector
600,000
0.0965%
$12.17$7.3M-67.88%
2019-12-16SaleBerg AaronCHIEF COMMERCIAL OFFICER
86,506
0.02%
$19.03$1.65M-70.15%
2019-12-16SaleZakrzewski Joseph Sdirector
200,000
0.0424%
$17.42$3.48M-70.15%
2019-12-16SaleKalb Michael WayneSVP and CFO
50,000
0.0142%
$23.36$1.17M-70.15%
Total: 191
*Gray background shows transactions not older than one year

Insider Historical Profitability

15.45%
Berg AaronPresident and CEO
805380
0.1958%
$333,266.2414
THERO JOHN FPresident and CEO
2739000
0.666%
$1.13M69+65.82%
Holt PatrickPresident and CEO
314426
0.0765%
$130,109.4820<0.0001%
Zakrzewski Joseph Sdirector
196547
0.0478%
$81,331.15316<0.0001%
WOLD OLSEN PER
149000
0.0362%
$61,656.2010<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$2,924,567
72
-4.87%
$157.74M
$613,304,943
46
11.85%
$191.55M
$48,218,096
42
0.89%
$204.72M
$79,019,806
27
7.24%
$165.26M
$6,915,275
21
-32.61%
$158.47M

AMRN Institutional Investors: Active Positions

Increased Positions55+26.57%10M+15.69%
Decreased Positions72-34.78%4M-6.46%
New Positions27New4MNew
Sold Out Positions23Sold Out388,145Sold Out
Total Postitions190-8.21%72M+9.23%

AMRN Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Sarissa Capital Management Lp$13,469.006.05%24.85M00%2024-12-31
Kynam Capital Management, Lp$6,729.003.02%12.41M00%2024-12-31
Morgan Stanley$2,388.001.07%4.41M+2M+73.09%2024-12-31
Scp Investment, Lp$1,355.000.61%2.5M00%2024-12-31
Waterfront Wealth Inc.$1,345.000.6%2.48M+2M+181.44%2024-12-31
Two Sigma Investments, Lp$1,178.000.53%2.17M-206,279-8.67%2024-12-31
Acadian Asset Management Llc$968.000.44%1.79M+2M+578.97%2024-12-31
Two Sigma Advisers, Lp$943.000.42%1.74M-236,700-11.98%2024-12-31
Longitude (Cayman) Ltd.$878.000.39%1.62M-750,000-31.65%2024-12-31
Eversept Partners, Lp$822.000.37%1.52M-2M-54.17%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.